Statins for COVID-19 Treatment Statins are lipid-lowering HMG-CoA reductase drugs which are sued in the management and treatment of cardiovascular diseases. Since statins have anti-inflammatory and antithrombotic properties therefore a hypothesis presents this drug class as a potential treatment of COVID-19. They also have the tendency to improve endothelial function. Currently, several research trials are being conducted to recommend statins for the treatment of COVID-19. No authority recommends it for the concerned purpose due to limited data.